CN1058409C - Medicine for quickly curing osteoproliferation - Google Patents

Medicine for quickly curing osteoproliferation Download PDF

Info

Publication number
CN1058409C
CN1058409C CN96119419A CN96119419A CN1058409C CN 1058409 C CN1058409 C CN 1058409C CN 96119419 A CN96119419 A CN 96119419A CN 96119419 A CN96119419 A CN 96119419A CN 1058409 C CN1058409 C CN 1058409C
Authority
CN
China
Prior art keywords
present
medicine
symptoms
rhizoma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96119419A
Other languages
Chinese (zh)
Other versions
CN1148500A (en
Inventor
付志昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96119419A priority Critical patent/CN1058409C/en
Publication of CN1148500A publication Critical patent/CN1148500A/en
Application granted granted Critical
Publication of CN1058409C publication Critical patent/CN1058409C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention belongs to a Chinese patent medicine for treating bone retrograde affection. Through clinical research for years, the pathogenic mechanisms of bone retrograde affection are held, and the clinical manifestation belongs to small joint disease or named as small joint functional disorder. The theory of the treatment of both symptoms and root causes of diseases of traditional Chinese medicine is adopted, and the present invention takes effects on 'evil repletion positive weakness'. The formula of the present invention has the functions of activating blood circulation to dissipate blood stasis, expelling wind, eliminating cold, regulating qi-flowing for relieving pain, invigorating the kidney, strengthening the bones for generating pith and inhibiting hyperosteogeny. The formula comprises cholera of sheep, rhizoma cibotii, prepared rhizome of rehmannia, rhizoma drynariae, cistanche salsa, suberect spatholobus, safflower, corydalis tuber and sugar or honey as assistance. The effective rate of the present invention is 95.4%, and the cure rate is 87.2%. Common symptoms can be cured for 20 days, serious symptoms can be obviously lightened, and the present invention can prevent the states of illness from relapsing.

Description

A kind of medicine for the treatment of hyperosteogeny
The invention belongs to the Chinese patent medicine of treatment sclerotin degeneration, particularly a kind ofly can cure hyperosteogeny in a short time, a kind of medicine for the treatment of hyperosteogeny that does not recur.
Hyperosteogeny disease (sclerotin degeneration) is one of Orthopeadic Surgery commonly encountered diseases frequently-occurring disease, and it is perplexing the healthy of numerous middle-aged and elderly people, even makes it disability, causes lifelong misery.The treatment of this disease is paced up and down at balky state always, becomes a difficult problem of not separating, and it is following four kinds that present Therapeutic Method does not have outer: the firstth, and relatively Chang Yong oral medicine such as bony spur tablet, oral liquid etc.; The secondth, general externally applied liniment, external application plaster etc.; The 3rd is manipulation, as therapies such as massage, massage, the qigong; The 4th is operative treatment, but its nearly long-term effect is all not satisfactory, and above-mentioned therapy subtracts the disease therapy logical the genus, in case withdrawal symptom can occur once again.
The purpose of this invention is to provide a kind of table, this double controlling, eliminate in a short time or mitigation symptoms, restore funcitons is also regulated the whole body function by medicine, effectively controls whole body sclerotin hypertrophy once again, and a kind of medicine for the treatment of hyperosteogeny of the change of the outgrowth bone of graduation.
Through for many years to the summary of year clinical trial surplus the research and 20 of sclerotin degeneration mechanism, its clinical symptoms all belongs to the vertebral articulations disease and also claims little joint disease or little joint function disorder, mainly be meant joint of lumbar vertebra and cervical vertebra joint, latter's symptom outstanding and more after also the most bad.Cause and the interior external variation of being familiar with osteoproliferation disease with theory of Chinese medical science then belong to liver unit thanks to void, deficiency of liver-blood, the skeleton development is latent to be split, overworks slightly or wound, just cause stagnation of QI-blood and do to ache, muscles is not hard in addition, once frequent activities, wearing and tearing, then cause the too early too fast degenerative change in little joint; The 2nd,, momentary and super mobility external force or strain, acting on spinal column, can to cause that QI and blood takes place for stressed the most concentrated part disorderly contrary, heavy then cause bone injury, blood oozing from the body openings or subcuta neous tissue arteries and veins, to form blood stasis sluggish, cause the vertebral bones structural damage, lose nourishing, the skeleton degeneration that occurs of a specified duration; The 3rd, the affection of exogenous wind-cold damp its by the body intrinsic factor, deficiency of kidney-QI often congenitally loses emptyly, skeletal structure is bad, or muscles is not hard, then feels exopathogen, the circular flow of blocking solution QI and blood does not freely form pathogenic factor.
With this, emphasis is caught " domination of pathogen is weakened body resistance " in treatment: blood circulation promoting and blood stasis dispelling, expelling wind and cold, regulating QI to relieve pain, invigorating the kidney and strengthening the bones are given birth to marrow, suppress hyperosteogeny, are regulated and recover little function of joint, thereby reach therapeutic purposes.The clinical treatment of year Chinese patent medicine Cheng Fang is developed into following prescription surplus 20 in view of the above: (weight g)
Folium Epimedii 25-50 Rhizoma Cibotii 25-50 Radix Rehmanniae Preparata 25-50 Rhizoma Drynariae 15-25
Herba Cistanches 15-25 Caulis Spatholobi 15-25 Rhizoma Corydalis 10-15 Flos Carthami 25-50
Brown sugar 50-150 or an amount of Mel are made decoction, electuary, pill, powder, tablet etc.
The present invention is year clinical constantly perfect surplus 20, name surplus the treatment patient 2000 on the books, its cure rate 87.2%, effective percentage 95.4%, men and women's indifference, sick time is short, the age is little is directly proportional with effective percentage, cure rate, treats general symptom with this medicine and takes medicine and can heal entirely in 20 days, and weight person's symptom obviously alleviates and can control pathological changes no longer repeatedly.
Embodiment:
Folium Epimedii 50g, Rhizoma Cibotii 50g, Radix Rehmanniae Preparata 50g, Rhizoma Drynariae 25g Herba Cistanches 25g, Caulis Spatholobi 25g, Rhizoma Corydalis 15g, Flos Carthami 50g, above medical herbs adds decocting and becomes the 500ml decoction, is potion with brown sugar 150g, each agent clothes five days, four doses (obeying 20 days) are a course of treatment, can fully recover.

Claims (1)

1, a kind of medicine for the treatment of hyperosteogeny is characterized in that said composition is decoction, pill, electuary, powder, the tablet of being made by the following raw materials by weight proportions thing:
Folium Epimedii 25~50g Rhizoma Cibotii 25~50g Radix Rehmanniae Preparata 20~50g
Rhizoma Drynariae 15~25g Herba Cistanches 15~25g Caulis Spatholobi 15~25g
Rhizoma Corydalis 10~15g Flos Carthami 15~25g brown sugar 50~150g or an amount of Mel.
CN96119419A 1996-09-18 1996-09-18 Medicine for quickly curing osteoproliferation Expired - Fee Related CN1058409C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96119419A CN1058409C (en) 1996-09-18 1996-09-18 Medicine for quickly curing osteoproliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96119419A CN1058409C (en) 1996-09-18 1996-09-18 Medicine for quickly curing osteoproliferation

Publications (2)

Publication Number Publication Date
CN1148500A CN1148500A (en) 1997-04-30
CN1058409C true CN1058409C (en) 2000-11-15

Family

ID=5125680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96119419A Expired - Fee Related CN1058409C (en) 1996-09-18 1996-09-18 Medicine for quickly curing osteoproliferation

Country Status (1)

Country Link
CN (1) CN1058409C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110478422A (en) * 2019-07-16 2019-11-22 山东快愈烂足中医药科技有限公司 A kind of oral medicine and preparation method thereof for treating lumbar vertebrae cervical vertebrae hyperosteogeny and disc herniation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107184728A (en) * 2017-05-22 2017-09-22 漯河医学高等专科学校 A kind of collaterals and relieving pain cream and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1087541A (en) * 1993-09-23 1994-06-08 高学泰 A kind of medicine for the treatment of lumbar vertebra hyperosteogeny diseases
CN1097131A (en) * 1993-07-07 1995-01-11 汪孝文 Ganling Dan

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097131A (en) * 1993-07-07 1995-01-11 汪孝文 Ganling Dan
CN1087541A (en) * 1993-09-23 1994-06-08 高学泰 A kind of medicine for the treatment of lumbar vertebra hyperosteogeny diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110478422A (en) * 2019-07-16 2019-11-22 山东快愈烂足中医药科技有限公司 A kind of oral medicine and preparation method thereof for treating lumbar vertebrae cervical vertebrae hyperosteogeny and disc herniation

Also Published As

Publication number Publication date
CN1148500A (en) 1997-04-30

Similar Documents

Publication Publication Date Title
CN100376276C (en) Soothe tendons and activating-blood anodyne plaster
CN1634225A (en) Medicine for reducing swelling, easing pain, promoting bone reunion and the preparation process thereof
CN101757148A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN100534480C (en) Bone-setting medicine and preparation method thereof
CN1170566C (en) Externally applied pain-relieving plaster and its prepn
CN101549137A (en) Chinese medicine preparation for treating bone joint disease
CN1069527C (en) Medicine for hyperosteogeny and wind-cold syndrome
CN100522216C (en) Medicine for treating traumatic injury
CN101991742A (en) Traditional Chinese medicine formula for treating lumbar disc herniation
CN101293041B (en) Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis
CN1058409C (en) Medicine for quickly curing osteoproliferation
CN1234385C (en) Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia
CN102198246B (en) Chinese medicinal preparation for treating bone diseases
CN100542583C (en) A kind of pharmaceutical composition for the treatment of vertebra and arthropathy
CN1112206C (en) Bone fracture setting medicine powder
CN102526418B (en) Drug for treating lumbar disc herniation and preparation method thereof
CN102430050B (en) Black plaster for treating bone injury
CN101284087B (en) Medicinal composition for curing lumbar disease
CN101439136B (en) Plaster for treating bone disease and soft tissue injury
CN101417059B (en) Ointment for treating burn and scald and preparation method thereof
CN100475247C (en) External application medicine for treating vertebrae lumbales hyperosteogeny
CN1060076C (en) Gucixiao pill for removing spur
CN1899564B (en) External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
CN102579581A (en) Medicine for treating lumbar disc herniation and preparation method thereof
CN1175852C (en) Medicine for treating hyperosteogeny

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee